{
    "code": "52026682",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026682",
    "time": "2021-03-12 04:03:32",
    "許可證字號": "衛部藥輸字第026682號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/02\/02",
    "發證日期": "105\/02\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202668202",
    "中文品名": "歐欣尼膜衣錠12.5毫克\/30毫克",
    "英文品名": "Oseni Tablets 12.5mg\/30mg",
    "適應症": "Oseni (alogliptinJpioglitazone)可用於以下狀況之成年第二型糖尿病治療:\r\n(1)\t使用alogliptin 單方每日25 mg 或pioglitazone 單方每日30 mg \r\n治療仍控制血糖不佳者。\r\n(2)\t與metformin 併用，本品適用於已使用alogliptin每日25 mg \r\n加上metformin(使用劑量≥每日1500 mg或已達最高耐受劑量)治\r\n療仍控制血糖不佳者、或已使用pioglitazone 每日15或30mg \r\n加上metfonnin(使用劑量≥全每日1500 mg 或已達最高耐受劑量)\r\n治療仍控制血糖不佳者。\r\n(3) 已使用alogliptin 以及pioglitazone 控制良好的患者，可與本藥品互換使用。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠PVC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/02\/02",
    "主成分略述": "PIOGLITAZONE HYDROCHLORIDE, Alogliptin benzoate",
    "限制項目": "02輸　入 1D須執行風險管理計畫 1Q不得輸入",
    "申請商名稱": "1406701200  台灣武田藥品工業股份有限公司",
    "申請商地址": "台北市信義區松高路1號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0328200  TAKEDA PHARMACEUTICAL COMPANY, LTD. (OSAKA PLANT)",
            "製造廠廠址": "17-85 JUSOHONMACHI 2-CHOME, YODOGAWA-KU OSAKA, JAPAN",
            "製造廠公司地址": "1-1 DOCHOMACHI 4-CHOME, CHUO-KU, OSAKA , JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "MUS2592000  Packaging Coordinators, LLC",
            "製造廠廠址": "2200 LAKE SHORE DRIVE WOODSTOCK, IL 60098 U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "分裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400910",
            "成分名稱": "PIOGLITAZONE HYDROCHLORIDE",
            "含量描述": "(As Pioglitazone......30MG)",
            "含量": "33.0600000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "6820602100",
            "成分名稱": "Alogliptin benzoate",
            "含量描述": "(As Alogliptin......12.5MG)",
            "含量": "17.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI_Oseni -C-USPI 201612_yenting20171106 (clean)_James Lu_201712_R8-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026682&Seq=004&Type=9"
        },
        {
            "title": "歐欣尼膜衣錠-中文仿單-107-09-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026682&Seq=003&Type=9"
        },
        {
            "title": "OSENI_Medication Guide_TFDA Requests_Colors version-105-05-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026682&Seq=003&Type=8"
        }
    ]
}